메뉴 건너뛰기




Volumn 268, Issue 4, 2010, Pages 390-394

Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia: Letter to the Editor

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23;

EID: 77956313516     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02262.x     Document Type: Letter
Times cited : (48)

References (15)
  • 1
    • 0033847087 scopus 로고    scopus 로고
    • Tumor-induced osteomalacia and the regulation of phosphate homeostasis
    • Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 2000 27 : 333 338.
    • (2000) Bone , vol.27 , pp. 333-338
    • Kumar, R.1
  • 2
    • 9144231813 scopus 로고    scopus 로고
    • Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature
    • Folpe AL, Fanburg-Smith JC, Billings SD et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004 28 : 1 30.
    • (2004) Am J Surg Pathol , vol.28 , pp. 1-30
    • Folpe, A.L.1    Fanburg-Smith, J.C.2    Billings, S.D.3
  • 3
    • 0032865417 scopus 로고    scopus 로고
    • Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia - A case report
    • Fukumoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia - a case report. Bone 1999 25 : 375 377.
    • (1999) Bone , vol.25 , pp. 375-377
    • Fukumoto, S.1    Takeuchi, Y.2    Nagano, A.3    Fujita, T.4
  • 4
    • 34147138937 scopus 로고    scopus 로고
    • PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia
    • Roarke MC, Nguyen BD. PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 2007 32 : 300 301.
    • (2007) Clin Nucl Med , vol.32 , pp. 300-301
    • Roarke, M.C.1    Nguyen, B.D.2
  • 5
    • 14944360740 scopus 로고    scopus 로고
    • Octreotide therapy for tumor-induced osteomalacia
    • Seufert J, Ebert K, Muller J et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001 345 : 1883 1888.
    • (2001) N Engl J Med , vol.345 , pp. 1883-1888
    • Seufert, J.1    Ebert, K.2    Muller, J.3
  • 6
    • 14344279878 scopus 로고    scopus 로고
    • Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
    • Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001 98 : 6500 6505.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 6500-6505
    • Shimada, T.1    Mizutani, S.2    Muto, T.3
  • 7
    • 20244368616 scopus 로고    scopus 로고
    • Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia
    • Jonsson KB, Zahradnik R, Larsson T et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003 348 : 1656 1663.
    • (2003) N Engl J Med , vol.348 , pp. 1656-1663
    • Jonsson, K.B.1    Zahradnik, R.2    Larsson, T.3
  • 8
    • 18744371012 scopus 로고    scopus 로고
    • Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
    • Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002 87 : 4957 4960.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4957-4960
    • Yamazaki, Y.1    Okazaki, R.2    Shibata, M.3
  • 9
    • 4043052503 scopus 로고    scopus 로고
    • Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
    • Takeuchi Y, Suzuki H, Ogura S et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004 89 : 3979 3982.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 3979-3982
    • Takeuchi, Y.1    Suzuki, H.2    Ogura, S.3
  • 10
    • 45849113239 scopus 로고    scopus 로고
    • Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23
    • Nasu T, Kurisu S, Matsuno S et al. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med 2008 47 : 957 961.
    • (2008) Intern Med , vol.47 , pp. 957-961
    • Nasu, T.1    Kurisu, S.2    Matsuno, S.3
  • 12
    • 48949088406 scopus 로고    scopus 로고
    • Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia
    • Westerberg PA, Olauson H, Toss G et al. Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia. Endocr Pract 2008 14 : 362 367.
    • (2008) Endocr Pract , vol.14 , pp. 362-367
    • Westerberg, P.A.1    Olauson, H.2    Toss, G.3
  • 13
    • 18744371012 scopus 로고    scopus 로고
    • Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
    • Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002 87 : 4957 4960.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4957-4960
    • Yamazaki, Y.1    Okazaki, R.2    Shibata, M.3
  • 14
    • 15644373713 scopus 로고    scopus 로고
    • A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: Evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets
    • Econs MJ, Friedman NE, Rowe PS et al. A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 1998 83 : 3459 3462.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3459-3462
    • Econs, M.J.1    Friedman, N.E.2    Rowe, P.S.3
  • 15
    • 68849127439 scopus 로고    scopus 로고
    • Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemia
    • Shimizu Y, Tada Y, Yamauchi M et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 2009 45 : 814 816.
    • (2009) Bone , vol.45 , pp. 814-816
    • Shimizu, Y.1    Tada, Y.2    Yamauchi, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.